Mitsubishi Tanabe Pharma Corp (4508.T)
4508.T on Tokyo Stock Exchange
1,470JPY
19 Apr 2019
1,470JPY
19 Apr 2019
Change (% chg)
¥-2 (-0.14%)
¥-2 (-0.14%)
Prev Close
¥1,472
¥1,472
Open
¥1,480
¥1,480
Day's High
¥1,489
¥1,489
Day's Low
¥1,462
¥1,462
Volume
630,500
630,500
Avg. Vol
1,053,279
1,053,279
52-wk High
¥2,208
¥2,208
52-wk Low
¥1,445
¥1,445
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Dec | 122,769.00 | 29.382 |
| Sep | 104,359.00 | 19.672 | |
| Jun | 105,351.00 | 24.890 | |
| FY 2018 | Mar '18 | 94,542.00 | 10.441 |
| Dec | 125,957.00 | 39.731 | |
| Sep | 105,648.00 | 22.905 | |
| Jun | 107,708.00 | 30.270 | |
| FY 2017 | Mar '17 | 99,625.00 | 19.728 |
| Dec | 120,237.00 | 42.602 | |
| Sep | 98,622.00 | 25.658 | |
| Jun | 105,493.00 | 39.044 |
*Note: Units in Millions ofYen
**Note: Units in Yen
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 1 | 103,300.00 | 103,300.00 | 103,300.00 | -- |
| Year Ending Mar-19 | 8 | 433,172.00 | 436,500.00 | 429,500.00 | 433,027.00 |
| Year Ending Mar-20 | 8 | 427,238.00 | 443,000.00 | 397,000.00 | 432,590.00 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 2 | 16.35 | 18.90 | 13.80 | -- |
| Year Ending Mar-19 | 9 | 75.04 | 88.27 | 41.89 | 113.22 |
| Year Ending Mar-20 | 9 | 78.60 | 101.64 | 52.78 | 104.95 |
| LT Growth Rate (%) | 2 | -6.89 | -5.00 | -8.78 | -9.68 |
Sales and Profit Figures in Japanese Yen (JPY);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 21.98 | 29.30 | 32.55 | |
| P/E High - Last 5 Yrs. | 29.28 | 43.17 | 48.10 | |
| P/E Low - Last 5 Yrs. | 17.83 | 22.71 | 23.42 | |
| Beta | 0.26 | 0.86 | 0.87 | |
| Price to Sales (TTM) | 3.42 | 6.59 | 8.39 | |
| Price to Book (MRQ) | 1.68 | 5.12 | 5.27 | |
| Price to Tangible Book (MRQ) | 2.02 | 5.84 | 6.74 | |
| Price to Cash Flow (TTM) | 19.51 | 23.07 | 24.13 | |
| % Owned Institutions | -- | 0.87 | 1.65 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 2.00 | 1.43 | 1.35 | |
| Dividend Yield - 5 Year Avg | 2.38 | 1.45 | 1.37 | |
| Dividend 5 Year Growth Rate | 8.24 | 3.99 | 4.70 | |
| Payout Ratio(TTM) | 43.97 | 42.19 | 39.61 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 2.10 | 5.43 | 13.46 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -1.48 | 6.61 | 8.04 | |
| Sales - 5 Yr. Growth Rate | 0.81 | 10.48 | 10.85 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -22.47 | 45.67 | 47.73 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 5.78 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 12.81 | 9.90 | 10.46 | |
| Capital Spending - 5 Yr. Growth Rate | 14.25 | 15.26 | 14.68 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 7.39 | 2.07 | 2.18 |
| Current Ratio (MRQ) | 8.30 | 2.87 | 2.98 |
| LT Debt to Equity (MRQ) | 0.33 | 8.87 | 11.32 |
| Total Debt to Equity (MRQ) | 3.10 | 12.86 | 16.01 |
| Interest Coverage (TTM) | -- | 32.48 | 28.44 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 60.83 | 52.10 | 52.41 | |
| Gross Margin - 5 Yr. Avg. | 60.62 | 49.66 | 50.39 | |
| EBITD Margin (TTM) | 22.70 | -- | -- | |
| EBITD - 5 Yr. Avg | 21.22 | 17.26 | 12.41 | |
| Operating Margin (TTM) | 20.16 | 13.53 | 5.77 | |
| Operating Margin - 5 Yr. Avg. | 16.83 | 13.69 | 8.01 | |
| Pre-Tax Margin (TTM) | 20.59 | 11.88 | 4.79 | |
| Pre-Tax Margin - 5 Yr. Avg. | 18.22 | 14.09 | 8.29 | |
| Net Profit Margin (TTM) | 15.03 | 8.79 | 1.52 | |
| Net Profit Margin - 5 Yr. Avg. | 11.95 | 10.58 | 4.70 | |
| Effective Tax Rate (TTM) | 27.00 | 22.12 | 22.13 | |
| Effective Tax Rate - 5 Yr. Avg. | 34.42 | 22.26 | 22.58 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 58,542,860 | 928,597,997 | 820,412,980 | |
| Net Income/Employee (TTM) | 8,800,412 | 105,162,136 | 92,866,230 | |
| Receivable Turnover (TTM) | 3.33 | 5.84 | 5.82 | |
| Inventory Turnover (TTM) | 2.27 | 2.57 | 3.41 | |
| Asset Turnover (TTM) | 0.44 | 0.93 | 0.90 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 6.67 | 10.98 | 10.60 | |
| Return on Assets - 5 Yr. Avg. | 5.52 | 12.41 | 11.78 | |
| Return on Investment (TTM) | 7.37 | 14.23 | 13.83 | |
| Return on Investment - 5 Yr. Avg. | 6.20 | 16.18 | 15.32 | |
| Return on Equity (TTM) | 7.89 | 15.46 | 15.25 | |
| Return on Equity - 5 Yr. Avg. | 6.59 | 17.07 | 16.41 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -0.42 | 0.90 | 0.81 |
| EPS (TTM) % | 20.16 | 16.22 | 12.81 |
| Dividend % | 13.04 | 9.14 | 8.24 |
Note: Units in Millions of US Dollars
Performance for Mitsubishi Tanabe Pharma Corp
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -0.80 | -6.31 | 99 | 29 |
| 13 Week | -1.07 | -5.76 | 99 | 42 |
| 26 Week | 10.60 | -2.34 | 99 | 44 |
| 52 Week | 20.49 | -3.31 | 99 | 11 |
| YTD | 13.34 | 2.02 | 99 | 38 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 16.85% |
| # of Holders: | 240 |
| Total Shares Held: | 94,582,390 |
| 3 Mo. Net Change: | 647,771 |
| # New Positions: | 7 |
| # Closed Positions: | 4 |
| # Increased Positions: | 57 |
| # Reduced Positions: | 40 |
| # Net Buyers: | 17 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.